Clinical trial
Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly
NCT06571383 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- September 17, 2024
- Completion date
- November 15, 2031
- Enrollment
- 500 (estimated)
- Sites
- 93
Conditions
As the registry lists them; a condition with its own page is linked.